261 related items for PubMed ID: 27448273
1. Differential Activation in Amygdala and Plasma Noradrenaline during Colorectal Distention by Administration of Corticotropin-Releasing Hormone between Healthy Individuals and Patients with Irritable Bowel Syndrome.
Tanaka Y, Kanazawa M, Kano M, Morishita J, Hamaguchi T, Van Oudenhove L, Ly HG, Dupont P, Tack J, Yamaguchi T, Yanai K, Tashiro M, Fukudo S.
PLoS One; 2016; 11(7):e0157347. PubMed ID: 27448273
[Abstract] [Full Text] [Related]
2. Relationship between sympathoadrenal and pituitary-adrenal response during colorectal distention in the presence of corticotropin-releasing hormone in patients with irritable bowel syndrome and healthy controls.
Tanaka Y, Kanazawa M, Kano M, Tashiro M, Fukudo S.
PLoS One; 2018; 13(7):e0199698. PubMed ID: 29979696
[Abstract] [Full Text] [Related]
3. Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation.
Fukudo S.
J Gastroenterol; 2007 Jan; 42 Suppl 17():48-51. PubMed ID: 17238026
[Abstract] [Full Text] [Related]
4. Altered brain and gut responses to corticotropin-releasing hormone (CRH) in patients with irritable bowel syndrome.
Kano M, Muratsubaki T, Van Oudenhove L, Morishita J, Yoshizawa M, Kohno K, Yagihashi M, Tanaka Y, Mugikura S, Dupont P, Ly HG, Takase K, Kanazawa M, Fukudo S.
Sci Rep; 2017 Sep 29; 7(1):12425. PubMed ID: 28963545
[Abstract] [Full Text] [Related]
5. Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome.
Sagami Y, Shimada Y, Tayama J, Nomura T, Satake M, Endo Y, Shoji T, Karahashi K, Hongo M, Fukudo S.
Gut; 2004 Jul 29; 53(7):958-64. PubMed ID: 15194643
[Abstract] [Full Text] [Related]
6. Effect of alpha-helical CRH on quantitative electroencephalogram in patients with irritable bowel syndrome.
Tayama J, Sagami Y, Shimada Y, Hongo M, Fukudo S.
Neurogastroenterol Motil; 2007 Jun 29; 19(6):471-83. PubMed ID: 17564629
[Abstract] [Full Text] [Related]
7. The effect of sex and irritable bowel syndrome on HPA axis response and peripheral glucocorticoid receptor expression.
Videlock EJ, Shih W, Adeyemo M, Mahurkar-Joshi S, Presson AP, Polytarchou C, Alberto M, Iliopoulos D, Mayer EA, Chang L.
Psychoneuroendocrinology; 2016 Jul 29; 69():67-76. PubMed ID: 27038676
[Abstract] [Full Text] [Related]
8. Stress and visceral pain: focusing on irritable bowel syndrome.
Fukudo S.
Pain; 2013 Dec 29; 154 Suppl 1():S63-S70. PubMed ID: 24021863
[Abstract] [Full Text] [Related]
9. [Effects of heat-sensitive moxibustion on HPA axis in rats with irritable bowel syndrome].
Zhang H, Xie F, Gong H, Huang H, Chen S, Kang M, Fu Y.
Zhongguo Zhen Jiu; 2017 Dec 12; 37(12):1315-21. PubMed ID: 29354998
[Abstract] [Full Text] [Related]
10. Visceral hypersensitivity in irritable bowel syndrome.
Kanazawa M, Hongo M, Fukudo S.
J Gastroenterol Hepatol; 2011 Apr 12; 26 Suppl 3():119-21. PubMed ID: 21443723
[Abstract] [Full Text] [Related]
11. Central noradrenaline transporter availability is linked with HPA axis responsiveness and copeptin in human obesity and non-obese controls.
Schinke C, Hesse S, Rullmann M, Becker GA, Luthardt J, Zientek F, Patt M, Stoppe M, Schmidt E, Meyer K, Meyer PM, Orthgieß J, Blüher M, Kratzsch J, Ding YS, Then Bergh F, Sabri O.
Stress; 2019 Jan 12; 22(1):93-102. PubMed ID: 30369292
[Abstract] [Full Text] [Related]
12. Injection of corticotropin-releasing hormone into the amygdala aggravates visceral nociception and induces noradrenaline release in rats.
Su J, Tanaka Y, Muratsubaki T, Kano M, Kanazawa M, Fukudo S.
Neurogastroenterol Motil; 2015 Jan 12; 27(1):30-9. PubMed ID: 25359531
[Abstract] [Full Text] [Related]
13. Concordant pattern of the HPA axis response to visceral stimulation and CRH administration.
Yagihashi M, Kano M, Muratsubaki T, Morishita J, Kono K, Tanaka Y, Kanazawa M, Fukudo S.
Neurosci Res; 2021 Jul 12; 168():32-40. PubMed ID: 33785411
[Abstract] [Full Text] [Related]
14. [The gastrointestinal motor function in irritable bowel syndrome (IBS)].
Sagami Y, Hongo M.
Nihon Rinsho; 2006 Aug 12; 64(8):1441-5. PubMed ID: 16898609
[Abstract] [Full Text] [Related]
15. Impact of serotonin transporter gene polymorphism on brain activation by colorectal distention.
Fukudo S, Kanazawa M, Mizuno T, Hamaguchi T, Kano M, Watanabe S, Sagami Y, Shoji T, Endo Y, Hongo M, Itoyama Y, Yanai K, Tashiro M, Aoki M.
Neuroimage; 2009 Sep 12; 47(3):946-51. PubMed ID: 19426812
[Abstract] [Full Text] [Related]
16. Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress.
Posserud I, Agerforz P, Ekman R, Björnsson ES, Abrahamsson H, Simrén M.
Gut; 2004 Aug 12; 53(8):1102-8. PubMed ID: 15247175
[Abstract] [Full Text] [Related]
17. Corticotropin-releasing hormone receptor 1 antagonist blocks brain-gut activation induced by colonic distention in rats.
Saito K, Kasai T, Nagura Y, Ito H, Kanazawa M, Fukudo S.
Gastroenterology; 2005 Nov 12; 129(5):1533-43. PubMed ID: 16285953
[Abstract] [Full Text] [Related]
18. Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome.
Fukudo S, Nomura T, Hongo M.
Gut; 1998 Jun 12; 42(6):845-9. PubMed ID: 9691924
[Abstract] [Full Text] [Related]
19. Dissociation between ACTH and cortisol response in DEX-CRH test in patients with panic disorder.
Petrowski K, Wintermann GB, Kirschbaum C, Bornstein SR.
Psychoneuroendocrinology; 2012 Aug 12; 37(8):1199-208. PubMed ID: 22277728
[Abstract] [Full Text] [Related]
20. Resilience is decreased in irritable bowel syndrome and associated with symptoms and cortisol response.
Park SH, Naliboff BD, Shih W, Presson AP, Videlock EJ, Ju T, Kilpatrick L, Gupta A, Mayer EA, Chang L.
Neurogastroenterol Motil; 2018 Jan 12; 30(1):. PubMed ID: 28718999
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
